Therapeutic Potential of Human Chorionic Gonadotropin Against Overactive Bladder

Reprod Sci. 2016 Sep;23(9):1122-8. doi: 10.1177/1933719115614400. Epub 2015 Nov 6.

Abstract

Overactive bladder (OAB) is a common form of urinary incontinence, resulting from spontaneous and random contractions of the urinary bladder. The affected individuals have an uncontrollable urge to urinate and experience incontinence and nocturia, which can greatly reduce the quality of daily life. There are several drugs for the treatment, and all of them have serious side effects. The following findings suggested that human chorionic gonadotropin (hCG) has a therapeutic potential that is worth investigating for the treatment of OAB. The finding are (1) human detrusor muscle contains hCG receptors, (2) detrusor muscle becomes quiescent during pregnancy, (3) hCG can inhibit detrusor muscle contractions induced by cholinergic stimulation in rats, and (4) hCG can mimic the anticholinergic drug on detrusor muscle contractions.

Keywords: detrusor muscle; gonadotropins; hCG/LH receptors; overactive bladder; urinary bladder.

Publication types

  • Review

MeSH terms

  • Animals
  • Cholinergic Antagonists / therapeutic use
  • Chorionic Gonadotropin / therapeutic use*
  • Female
  • Humans
  • Luteinizing Hormone / physiology
  • Male
  • Receptors, LH / agonists
  • Receptors, LH / physiology
  • Urinary Bladder, Overactive / drug therapy*
  • Urinary Bladder, Overactive / physiopathology
  • Urinary Incontinence / drug therapy

Substances

  • Cholinergic Antagonists
  • Chorionic Gonadotropin
  • Receptors, LH
  • Luteinizing Hormone